Pelthos Therapeutics (PTHS) Cash & Equivalents (2022 - 2026)
Pelthos Therapeutics' Cash & Equivalents came in at $24.19 million for Q2 2026, compared with $59,000 a year earlier and down 24.3% from the prior quarter.
Powered by 
Analysis
Pelthos Therapeutics (PTHS) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Pelthos Therapeutics' Cash & Equivalents was $17.97 million.
- Cash & Equivalents carries a three-year compound annual growth rate of 588.5% (FY2022 to FY2025).
- Going back by year, Cash & Equivalents was $513,000 in FY2024 (+434.4%), $96,000 in FY2023 (+74.3%) and $55,074 in FY2022.
- The five-year range for quarterly Cash & Equivalents is $22,786 (Q3 2023) to $31.98 million (Q1 2026).
- Business Quant data shows PTHS's Cash & Equivalents at $31.98 million (Q1 2026), $17.97 million (Q4 2025) and $14.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Pelthos Therapeutics | 77.24 Mn | -11.16 Mn | 11.99 Mn | 24.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.19 Mn |
| Mar 31, 2026 | 31.98 Mn |
| Dec 31, 2025 | 17.97 Mn |
| Sep 30, 2025 | 14.25 Mn |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | 131,000.00 |
| Dec 31, 2024 | 513,000.00 |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 2.41 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 22,786.00 |
| Jun 30, 2023 | 81,893.00 |
| Mar 31, 2023 | 48,608.00 |
| Dec 31, 2022 | 55,074.00 |
API Access
Pelthos Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTHS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PTHS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTHS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();